MRI-guided Focused Ultrasound (MRgFUS) in Israel excludes patients with low skull density ratios, metallic implants, or severe claustrophobia. Neurological conditions like multiple sclerosis tremors are also ineligible. Disqualified candidates often transition to deep brain stimulation (DBS), advanced pharmacotherapy, or targeted botulinum toxin injections at major neurosurgical centers.
- Skull density: A skull density ratio (SDR) below 0.40–0.45 prevents effective ultrasound wave penetration.
- Metallic implants: Pacemakers, cochlear devices, and some dental braces pose MRI heating risks.
- Brain health: Active lesions, tumors, or large vascular malformations disqualify patients from MRgFUS.
- DBS alternative: Deep brain stimulation involves intracranial neurostimulator implantation and electrode placement in the thalamus.
Bookimed Expert Insight: Israeli neurosurgeons often pivot patients from MRgFUS to deep brain stimulation (DBS) if they present with severe bilateral tremors. While MRgFUS is highly effective for one-sided relief, DBS remains the preferred choice in Israel for long-term control of extensive, complex movements. Centers like Sourasky Medical Center and Sheba Medical Center offer comprehensive DBS packages around $50,000 to $58,300, which include the neurostimulator and specialist consultations.
Patient Consensus: Patients emphasize checking your skull density ratio (SDR) through specialized imaging long before traveling to avoid a last-minute rejection. Many find that while the ultrasound is non-invasive, deep brain stimulation is often a more reliable `Plan B` for those with physical barriers to MRgFUS.
